Full metadata record

DC Field Value Language
dc.contributor.authorChung, Seung Woo-
dc.contributor.authorKweon, Seho-
dc.contributor.authorLee, Beom Suk-
dc.contributor.authorKim, Gui Chul-
dc.contributor.authorMahmud, Foyez-
dc.contributor.authorLee, Hanul-
dc.contributor.authorCho, Young Seok-
dc.contributor.authorChoi, Jeong Uk-
dc.contributor.authorJeon, Ok-Cheol-
dc.contributor.authorKim, Ji Won-
dc.contributor.authorKim, Seong Who-
dc.contributor.authorKim, In-San-
dc.contributor.authorKim, Sang Yoon-
dc.contributor.authorByun, Youngro-
dc.date.accessioned2024-01-20T00:03:45Z-
dc.date.available2024-01-20T00:03:45Z-
dc.date.created2021-09-03-
dc.date.issued2017-11-01-
dc.identifier.issn0020-7136-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/122087-
dc.description.abstractChemotherapy have commonly been used in maximum tolerated dose to completely eradicate the cancer. However, such treatments often failed due to the complex and dynamic nature of cancer. Therefore, it has been suggested that cancer should be treated as a chronic disease, controlling its growth by providing continuous therapeutic pressure for long-term. Such an approach, however, requires a therapy that is non-toxic and orally available with sufficient potency. Herein, we propose a radiotherapy-assisted orally available metronomic apoptosis-targeted chemotherapy, which delivers doxorubicin continuously to the irradiated tumor with high selectivity while causing minimal toxicities to the normal tissues. DEVD-5-DOX/DCK complex is the anticancer prodrug for our strategy that could selectively release doxorubicin in the irradiated tumor tissue with sufficient oral bioavailability. The prodrug was completely inactive by itself, but displayed potent anticancer activity when coupled with radiotherapy. Consequently, the daily oral administration of DEVD-S-DOX/DCK in combination with the low-dose radiotherapy effectively suppressed the growth of tumor in vivo with no significant systemic toxicities despite that the accumulated dose of doxorubicin exceeded 150 mg/kg. Therefore, the our novel therapy using DEVD-S-DOX/DCK complex is considered as an outstanding treatment option for treating cancer for long-term attributed to its oral availability and low-toxicity profile as well as the potent anticancer effect.-
dc.languageEnglish-
dc.publisherWILEY-
dc.subjectNEGATIVE BREAST-CANCER-
dc.subjectRECURRENT OVARIAN-CANCER-
dc.subjectBILE-ACID ABSORPTION-
dc.subjectL-LYSYL-METHYLESTER-
dc.subject1ST-LINE CHEMOTHERAPY-
dc.subjectMAINTENANCE THERAPY-
dc.subjectDEOXYCHOLIC-ACID-
dc.subjectSMALL-INTESTINE-
dc.subjectIONIC COMPLEX-
dc.subjectCYCLOPHOSPHAMIDE-
dc.titleRadiotherapy-assisted tumor selective metronomic oral chemotherapy-
dc.typeArticle-
dc.identifier.doi10.1002/ijc.30842-
dc.description.journalClass1-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF CANCER, v.141, no.9, pp.1912 - 1920-
dc.citation.titleINTERNATIONAL JOURNAL OF CANCER-
dc.citation.volume141-
dc.citation.number9-
dc.citation.startPage1912-
dc.citation.endPage1920-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000408973500021-
dc.identifier.scopusid2-s2.0-85026669195-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalResearchAreaOncology-
dc.type.docTypeArticle-
dc.subject.keywordPlusNEGATIVE BREAST-CANCER-
dc.subject.keywordPlusRECURRENT OVARIAN-CANCER-
dc.subject.keywordPlusBILE-ACID ABSORPTION-
dc.subject.keywordPlusL-LYSYL-METHYLESTER-
dc.subject.keywordPlus1ST-LINE CHEMOTHERAPY-
dc.subject.keywordPlusMAINTENANCE THERAPY-
dc.subject.keywordPlusDEOXYCHOLIC-ACID-
dc.subject.keywordPlusSMALL-INTESTINE-
dc.subject.keywordPlusIONIC COMPLEX-
dc.subject.keywordPlusCYCLOPHOSPHAMIDE-
dc.subject.keywordAuthordrug delivery system-
dc.subject.keywordAuthormetronomic therapy-
dc.subject.keywordAuthororal chemotherapy-
dc.subject.keywordAuthorradiation-induced apoptosis-targeted chemotherapy-
dc.subject.keywordAuthortargeted therapy-
Appears in Collections:
KIST Article > 2017
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE